Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5042 | 1683 | 47.8 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
307 | 3 | INTEGRIN//ALPORT SYNDROME//LAMININ | 40384 |
683 | 2 | INTEGRIN//FOCAL ADHESION KINASE//TENASCIN C | 13145 |
5042 | 1 | INTEGRIN ALPHAVBETA3//CILENGITIDE//RGD PEPTIDE | 1683 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INTEGRIN ALPHAVBETA3 | authKW | 852805 | 5% | 54% | 87 |
2 | CILENGITIDE | authKW | 646348 | 3% | 76% | 47 |
3 | RGD PEPTIDE | authKW | 413756 | 7% | 21% | 111 |
4 | ALPHAVBETA3 | authKW | 376854 | 3% | 48% | 43 |
5 | MED ISOTOPES | address | 310541 | 3% | 40% | 43 |
6 | RGD | authKW | 293568 | 6% | 16% | 104 |
7 | INTEGRIN | authKW | 290580 | 21% | 5% | 356 |
8 | TC 99M 3PRGD2 | authKW | 218994 | 1% | 93% | 13 |
9 | ALPHAVBETA3 INTEGRIN | authKW | 209673 | 2% | 34% | 34 |
10 | INTETUMUMAB | authKW | 146946 | 1% | 90% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 3213 | 13% | 0% | 227 |
2 | Oncology | 3122 | 24% | 0% | 397 |
3 | Radiology, Nuclear Medicine & Medical Imaging | 2849 | 17% | 0% | 283 |
4 | Chemistry, Organic | 799 | 11% | 0% | 190 |
5 | Medicine, Research & Experimental | 747 | 9% | 0% | 150 |
6 | Pharmacology & Pharmacy | 490 | 12% | 0% | 208 |
7 | Biochemistry & Molecular Biology | 419 | 17% | 0% | 290 |
8 | Biochemical Research Methods | 411 | 6% | 0% | 103 |
9 | Cell Biology | 338 | 9% | 0% | 155 |
10 | Chemistry, Multidisciplinary | 109 | 8% | 0% | 141 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED ISOTOPES | 310541 | 3% | 40% | 43 |
2 | INTERDIPARTIMENTALE STUDI BIOMOL PLICAZ I | 90708 | 0% | 100% | 5 |
3 | CISPIM | 72567 | 0% | 100% | 4 |
4 | ONCOL PLATFORM | 72567 | 0% | 100% | 4 |
5 | MOL IMAGING NANOMED | 66265 | 1% | 15% | 25 |
6 | RADIOL MIPS | 58052 | 0% | 80% | 4 |
7 | INTER PRECLIN DEV MOL IMAGING CISPIM | 56689 | 0% | 63% | 5 |
8 | BONE BIOL OSTEOPOROSIS | 52987 | 1% | 19% | 15 |
9 | RADIOL BIOX | 48375 | 0% | 67% | 4 |
10 | MIPS | 42799 | 2% | 8% | 30 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THERANOSTICS | 19301 | 1% | 4% | 25 |
2 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 10427 | 3% | 1% | 43 |
3 | MOLECULAR IMAGING | 10267 | 1% | 4% | 16 |
4 | MOLECULAR IMAGING AND BIOLOGY | 9952 | 1% | 2% | 23 |
5 | BIOCONJUGATE CHEMISTRY | 8675 | 3% | 1% | 49 |
6 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 6542 | 1% | 2% | 23 |
7 | JOURNAL OF NUCLEAR MEDICINE | 5729 | 3% | 1% | 57 |
8 | NUCLEAR MEDICINE AND BIOLOGY | 5650 | 2% | 1% | 34 |
9 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 4076 | 1% | 3% | 9 |
10 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3236 | 4% | 0% | 68 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTEGRIN ALPHAVBETA3 | 852805 | 5% | 54% | 87 | Search INTEGRIN+ALPHAVBETA3 | Search INTEGRIN+ALPHAVBETA3 |
2 | CILENGITIDE | 646348 | 3% | 76% | 47 | Search CILENGITIDE | Search CILENGITIDE |
3 | RGD PEPTIDE | 413756 | 7% | 21% | 111 | Search RGD+PEPTIDE | Search RGD+PEPTIDE |
4 | ALPHAVBETA3 | 376854 | 3% | 48% | 43 | Search ALPHAVBETA3 | Search ALPHAVBETA3 |
5 | RGD | 293568 | 6% | 16% | 104 | Search RGD | Search RGD |
6 | INTEGRIN | 290580 | 21% | 5% | 356 | Search INTEGRIN | Search INTEGRIN |
7 | TC 99M 3PRGD2 | 218994 | 1% | 93% | 13 | Search TC+99M+3PRGD2 | Search TC+99M+3PRGD2 |
8 | ALPHAVBETA3 INTEGRIN | 209673 | 2% | 34% | 34 | Search ALPHAVBETA3+INTEGRIN | Search ALPHAVBETA3+INTEGRIN |
9 | INTETUMUMAB | 146946 | 1% | 90% | 9 | Search INTETUMUMAB | Search INTETUMUMAB |
10 | ALPHAVBETA3 ANTAGONISTS | 126992 | 0% | 100% | 7 | Search ALPHAVBETA3+ANTAGONISTS | Search ALPHAVBETA3+ANTAGONISTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DESGROSELLIER, JS , CHERESH, DA , (2010) INTEGRINS IN CANCER: BIOLOGICAL IMPLICATIONS AND THERAPEUTIC OPPORTUNITIES.NATURE REVIEWS CANCER. VOL. 10. ISSUE 1. P. 9 -22 | 82 | 44% | 1120 |
2 | LIU, S , (2015) RADIOLABELED CYCLIC RGD PEPTIDE BIOCONJUGATES AS RADIOTRACERS TARGETING MULTIPLE INTEGRINS.BIOCONJUGATE CHEMISTRY. VOL. 26. ISSUE 8. P. 1413 -1438 | 127 | 59% | 10 |
3 | CHEN, HJ , NIU, G , WU, H , CHEN, XY , (2016) CLINICAL APPLICATION OF RADIOLABELED RGD PEPTIDES FOR PET IMAGING OF INTEGRIN ALPHA(V)BETA(3).THERANOSTICS. VOL. 6. ISSUE 1. P. 78 -92 | 66 | 74% | 10 |
4 | LIU, S , (2009) RADIOLABELED CYCLIC RGD PEPTIDES AS INTEGRIN ALPHA(V)BETA(3)-TARGETED RADIOTRACERS: MAXIMIZING BINDING AFFINITY VIA BIVALENCY.BIOCONJUGATE CHEMISTRY. VOL. 20. ISSUE 12. P. 2199 -2213 | 85 | 71% | 170 |
5 | LIU, Z , WANG, F , (2013) DEVELOPMENT OF RGD-BASED RADIOTRACERS FOR TUMOR IMAGING AND THERAPY: TRANSLATING FROM BENCH TO BEDSIDE.CURRENT MOLECULAR MEDICINE. VOL. 13. ISSUE 10. P. 1487 -1505 | 75 | 72% | 19 |
6 | AUZZAS, L , ZANARDI, F , BATTISTINI, L , BURREDDU, P , CARTA, P , RASSU, G , CURTI, C , CASIRAGHI, G , (2010) TARGETING ALPHA(V)BETA(3) INTEGRIN: DESIGN AND APPLICATIONS OF MONO- AND MULTIFUNCTIONAL RGD-BASED PEPTIDES AND SEMIPEPTIDES.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 13. P. 1255 -1299 | 109 | 49% | 50 |
7 | SHELDRAKE, HM , PATTERSON, LH , (2014) STRATEGIES TO INHIBIT TUMOR ASSOCIATED INTEGRIN RECEPTORS: RATIONALE FOR DUAL AND MULTI-ANTAGONISTS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 57. ISSUE 15. P. 6301 -6315 | 80 | 57% | 18 |
8 | GAERTNER, FC , KESSLER, H , WESTER, HJ , SCHWAIGER, M , BEER, AJ , (2012) RADIOLABELLED RGD PEPTIDES FOR IMAGING AND THERAPY.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 39. ISSUE . P. 126 -138 | 54 | 76% | 78 |
9 | HAUBNER, R , DECRISTOFORO, C , (2009) RADIOLABELLED RGD PEPTIDES AND PEPTIDOMIMETICS FOR TUMOUR TARGETING.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 14. ISSUE . P. 872 -886 | 66 | 78% | 45 |
10 | ZHOU, Y , CHAKRABORTY, S , LIU, S , (2011) RADIOLABELED CYCLIC RGD PEPTIDES AS RADIOTRACERS FOR IMAGING TUMORS AND THROMBOSIS BY SPECT.THERANOSTICS. VOL. 1. ISSUE . P. 58 -82 | 107 | 43% | 50 |
Classes with closest relation at Level 1 |